San Diego Biotechnology Network: Biotech Events, Jobs, News, Companies, Directory, Blog, & Calendar » BioSpace

Bristol-Myers Squibb Company To Acquire ZymoGenetics, Inc. For $885 Million

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

LOS ANGELES, Sept 7 (Reuters) - Bristol-Myers Squibb Co (BMY.N) plans to acquire biotech drug developer ZymoGenetics Inc (ZGEN.O) in a deal valued at $885 million -- a premium of about 84 percent to Tuesday's closing share price.

Zogenix, Inc. Files For $90 Million IPO

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

SAN DIEGO, Sept. 7 /PRNewswire/ -- Zogenix, Inc. ("Zogenix") announced today that it has filed a registration statement with the Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for...

Zogenix, Inc. Files for $90 Million IPO

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

Spectrum Pharmaceuticals, Inc. to Present at the 2010 Healthcare Conference

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today reported that an overview of the Companys business strategy will be given at the Robert W. Baird & Co., Inc. 2010 Healthcare Conference, being held at the St. Regis Hotel in New York City...

CytRx Corporation to Present at Rodman & Renshaw 12th Annual Healthcare Conference

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Chief Medical Officer Daniel Levitt, MD, Ph.D., will be presenting at the 12th Annual Rodman & Renshaw Healthcare Conference on Tuesday, September 14, at 9:35 a.m. Eastern time (6:35 a.m. Pacific time...

ImmunoCellular Therapeutics, Ltd Announces Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Companys lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. The data show six...

Vical Incorporated to Present at Healthcare Conference

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

SAN DIEGO, Sept. 8, 2010 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company's President and Chief Executive Officer, Vijay B. Samant, will provide an overview of the company's technologies, development programs, and strategic partnerships at the Stifel Nicolaus 2010 Healthcare Conference (Boston, September 15 17).

Cylene Pharmaceuticals, Inc.e to Report Recent Advances With First-in-Class CK2 Inhibitor, CX-4945, at Conference

BioSpace.com Featured News — Wed, 08 Sep 2010 00:00:00 +0000

SAN DIEGO, Sept. 8 /PRNewswire/ -- Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany...

Cobalis Corp. Provides Marketing Update Conference Call for Investors

BioSpace.com Featured News — Tue, 07 Sep 2010 00:00:00 +0000

IRVINE, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Cobalis Corp. (Pink Sheets: CLSC) (www.cobalis.com) is pleased to announce that with our recent positive development of the PreHistin distribution network and imminent marketing launch, we will be conducting our first series...

Illumina, Inc. to Present at Upcoming Investment Conferences in September

BioSpace.com Featured News — Tue, 07 Sep 2010 00:00:00 +0000

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that the company will webcast its presentations at two upcoming investment conferences.